| 臺大學術典藏 |
2022-01-11T06:49:24Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
HSIEN-YI CHIU; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; Tsai T.-F.; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-10-28T07:11:19Z |
Correlation of clinical diagnosis of dactylitis by the dermatologist and ultrasonographic diagnosis by the rheumatologist in patients with psoriasis arthritis: Experience of a single clinic
|
Lo Y.; Wang T.-S.; Li K.-J.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2021-10-28T07:11:18Z |
Recommendations for psoriatic arthritis management: A joint position paper of the Taiwan Rheumatology Association and the Taiwanese Association for Psoriasis and Skin Immunology
|
TSEN-FANG TSAI; Hsieh T.-Y.; Chi C.-C.; Chou C.-T.; Hsieh L.-F.; Chen H.-H.; Hui R.C.-Y.; Lee C.-H.; Liu C.-H.; Liu H.-C.; Yeo K.-J.; Chen C.-H.; Chen H.-A.; Chen Y.-C.; Chen Y.-J.; Chiu H.-Y.; Ho J.-C.; Huang Y.-H.; Lai P.-J.; Lee W.-R.; Liao H.-T.; Lin S.-H.; Tseng J.-C.; Wang T.-S.; Wu N.-L.; Yang D.-H.; Tsai W.-C.; Wei J.C.-C.; Taiwan Rheumatology Association (TRA); the Taiwanese Association for Psoriasis; Skin Immunology (TAPSI) |
| 臺大學術典藏 |
2021-10-28T07:11:16Z |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu H.-Y.; Chiu Y.-M.; Chang Liao N.-F.; Chi C.-C.; TSEN-FANG TSAI; Hsieh C.-Y.; Hsieh T.-Y.; Lai K.-L.; Chiu T.-M.; Wu N.-L.; Hui R.C.-Y.; Lee C.-N.; Wang T.-S.; Chen P.-H.; Yang C.-C.; Huang Y.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:07Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2021-09-04T05:16:40Z |
Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients
|
Hsu S.-J.; Enkhzaya S.; Lin Y.-Y.; Tseng T.-C.; Khosbayar T.; Tsai C.-H.; Wang T.-S.; Enkhtuya D.; Ivshinkhorol D.; Naranzul N.; Jargalsaikhan B.; Amarsanaa J.; Baatarkhuu O.; JIA-HORNG KAO |
| 國立成功大學 |
2021 |
Predictors of hepatitis B and C virus reactivation in patients with psoriasis treated with biologic agents: a 9-year multicenter cohort study
|
Chiu, H.-Y.;Chiu, Y.-M.;Chang, Liao N.-F.;Chi, Chi C.-C.;Tsai, Tsai T.-F.;Hsieh, C.-Y.;Hsieh, T.-Y.;Lai, K.-L.;Chiu, T.-M.;Wu, N.-L.;Hui, R.C.-Y.;Lee, C.-N.;Wang, T.-S.;Chen, P.-H.;Yang, C.-C.;Huang, Y.-H. |
| 臺大學術典藏 |
2020-10-22T07:28:11Z |
Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan
|
Schenkel B.; Zhang M.; Tang C.-H.; Tsai P.I.C.; Wang T.-S.; Hung S.-T.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:05Z |
Safety and effectiveness of adalimumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to prior etanercept
|
Wang T.-S.;Tsen-Fang Tsai; Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:05Z |
Isolated erythematous plaque on the right cheek
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:03Z |
Intralesional therapy for psoriasis
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:02Z |
Remission of bullous pemphigoid after rituximab treatment in a psoriasis patient on regular low dose methotrexate
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:01Z |
Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
|
Wang T.-S.; Chiu H.-Y.; Wu L.S.-H.; Chu C.-Y.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:01Z |
Cutaneous irritancy of water
|
TSEN-FANG TSAI; Wang T.-S. |
| 臺大學術典藏 |
2020-10-22T07:28:01Z |
Occurrence of psoriatic plaques on previous adalimumab injection sites during disease relapse in a patient with pustular psoriasis
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:00Z |
Risk factor analysis for the immunogenicity of adalimumab associated with decreased clinical response in Chinese patients with psoriasis
|
Chiu H.-Y.; Wang T.-S.; Chan C.-C.; Lin S.-J.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:28:00Z |
Psoriasis sparing the lower limb with postpoliomyelitis residual paralysis
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:59Z |
Practical experience of ustekinumab in patients with moderate-to-severe psoriasis who had inadequate therapeutic response to previous tumor necrosis factor blockers
|
TSEN-FANG TSAI; Wang T.-C.; Chiu H.-Y.; Wang T.-S. |
| 臺大學術典藏 |
2020-10-22T07:27:57Z |
Correlation of IL36RN mutation with different clinical features of pustular psoriasis in Chinese patients
|
Wang T.-S.; Chiu H.-Y.; Hong J.-B.; Chan C.-C.; Lin S.-J.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:53Z |
Epidemiology of psoriatic disease and current treatment patterns from 2003 to 2013: A nationwide, population-based observational study in Taiwan
|
Wang T.-S.; Hsieh C.-F.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:52Z |
Managing Scalp Psoriasis: An Evidence-Based Review
|
Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:50Z |
Serial QuantiFERON-TB Gold testing in patients with psoriasis treated with ustekinumab
|
Hsiao C.-Y.; Chiu H.-Y.; Wang T.-S.; TSEN-FANG TSAI |
| 臺大學術典藏 |
2020-10-22T07:27:48Z |
Safety profile of secukinumab in treatment of patients with psoriasis and concurrent hepatitis B or C: A multicentric prospective cohort study
|
TSEN-FANG TSAI; Wang T.-S.; Lai P.-J.; Tsai Y.-C.; Chen K.-L.; Huang R.-Y.; Huang Y.-H.; Hui R.C.-Y.; Chiu H.-Y.; Chiu H.-Y.;Hui R.C.-Y.;Huang Y.-H.;Huang R.-Y.;Chen K.-L.;Tsai Y.-C.;Lai P.-J.;Wang T.-S.;Tsen-Fang Tsai |
| 臺大學術典藏 |
2020-10-22T07:27:48Z |
Tofacitinib in psoriatic arthritis
|
TSEN-FANG TSAI; Wang T.-S. |
| 臺大學術典藏 |
2020-10-22T07:27:45Z |
Psoriasis in Taiwan: From epidemiology to new treatments
|
Wang T.-S.; Chen P.-H.; Hsu S.-H.; Tsai Y.-C.; TSEN-FANG TSAI; Chiu H.-Y.;Wang T.-S.;Chen P.-H.;Hsu S.-H.;Tsai Y.-C.;Tsen-Fang Tsai; Chiu H.-Y. |
